August 31, 2016 12:21 PM ET

Biotechnology

Company Overview of PhaseBio Pharmaceuticals, Inc.

Key Executives for PhaseBio Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jonathan P. Mow MBA8 RelationshipsChief Executive Officer and Director51
Ashutosh Chilkoti Ph.D.8 RelationshipsCo-Founder and Director--
Clay Bernardin Thorp 56 RelationshipsExecutive Chairman47
John P. Sharp CPANo RelationshipsChief Financial Officer51
John S. Lee M.D., Ph.D.No RelationshipsChief Medical Officer--

PhaseBio Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Clay Bernardin Thorp 56 RelationshipsPhaseBio Pharmaceuticals, Inc.47
Jonathan P. Mow MBA 8 RelationshipsPhaseBio Pharmaceuticals, Inc.51
Ashutosh Chilkoti Ph.D. 8 RelationshipsPhaseBio Pharmaceuticals, Inc.--
Guy Fish M.D. 8 RelationshipsFletcher Spaght Ventures, LP--
Asish K. Xavier Ph.D. 28 RelationshipsJohnson & Johnson Innovation - JJDC, Inc.--
View All Board Members

PhaseBio Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
379.6K
Bonus
261.7K
Total Short Term Compensation
475.8K
Total Value of Options
33.3M
Compensation as of Fiscal Year
PhaseBio Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bionomics Ltd. Announces Board Changes
August 30, 2016 11:15 PM ET
Cellceutix Further Expands its Senior Management Team
August 30, 2016 6:07 PM ET
Tizona Therapeutics, Inc. Appoints George Golumbeski to Board of Directors
August 30, 2016 1:00 PM ET
Nutra Pharma Announces Addition of Kenneth Dowd to its Advisory Board
August 30, 2016 12:30 PM ET
Pliant Therapeutics Appoints Suzanne Bruhn, Ph.D., to its Board of Directors
August 30, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PhaseBio Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.